Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pelvic Neoplasms 1Chylous Ascites 1Abdominal Neoplasms 1

Interventions

Radiotherapy 4Surveys and Questionnaires 3Specimen Handling 2Iohexol 2Gemcitabine 2spartalizumab 1sodium thiosulfate 1serotonin adipinate 1liposomal doxorubicin 1X-Rays 1Watchful Waiting 1Vorinostat 1Surgical Procedures, Operative 1Sunitinib 1Solutions 1Serotonin 1Saline Solution 1Re-Irradiation 1Radiotherapy, Image-Guided 1Radiosurgery 1Probiotics 1Platinum 1Particle Accelerators 1Pafolacianine 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Lidocaine 1Ketamine 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pelvic Neoplasms × Embolization, Therapeutic × Gynecologic × Clear all
NCT06820320 2026-03-06

Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Completed
42 enrolled
Gynecologic

Abdominal Neoplasms, Chylous Ascites, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡